The Efficacy of YKL-40 and CA125 as Biomarkers for Epithelial Ovarian Cancer

Brazilian Journal of Medical and Biological Research - Brazil
doi 10.1590/s0100-879x2010007500133
Full Text
Abstract

Available in full text

Date
Authors
Publisher

FapUNIFESP (SciELO)

Related search

The Use of HE4, CA125 and CA72-4 Biomarkers for Differential Diagnosis Between Ovarian Endometrioma and Epithelial Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2013English

Cerebrospinal Fluid Neurogranin and YKL-40 as Biomarkers of Alzheimer's Disease

Annals of Clinical and Translational Neurology
NeuroscienceNeurology
2015English

Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer

Cancer Prevention Research
MedicineCancer ResearchOncology
2019English

Biomarkers and Algorithms for Diagnosis of Ovarian Cancer: CA125, HE4, RMI and ROMA, a Review

Journal of Ovarian Research
GynecologyOncologyObstetrics
2019English

Serum YKL-40 and Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
1999English

Glypican-4, YKL-40 and Neuregulin-4 as Novel Biomarkers in Polycystic Ovary Syndrome

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2018English

Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer

Clinical Cancer Research
Cancer ResearchOncology
2017English

The Clinical Correlates of Serum CA125 in 169 Patients With Epithelial Ovarian Carcinoma

British Journal of Cancer
Cancer ResearchOncology
1989English

Predictors of Pretreatment CA125 at Ovarian Cancer Diagnosis: A Pooled Analysis in the Ovarian Cancer Association Consortium

Cancer Causes and Control
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy